title: A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).
authors.affiliation: Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892-1750, USA. pa52s@nih.gov
authors.forename: Philip M
authors.initials: PM
authors.lastname: Arlen
authors.forename: Mary
authors.initials: M
authors.lastname: Pazdur
authors.forename: Lisa
authors.initials: L
authors.lastname: Skarupa
authors.forename: Myrna
authors.initials: M
authors.lastname: Rauckhorst
authors.forename: James L
authors.initials: JL
authors.lastname: Gulley
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D019496:Cancer Vaccines / Q000008:administration & dosage; D017322:Clinical Trials, Phase II as Topic; D000077143:Docetaxel; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D011212:Poxviridae / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D019496:Cancer Vaccines; D043823:Taxoids; D000077143:Docetaxel